Osso VR announced today that it has raised $27 million in a Series B round as it seeks to fuel further growth around its virtual reality surgical training and assessment platform.
GSR Ventures led the round, with participation from Signalfire, Kaiser Permanente Ventures, OCA Ventures, Scrum Ventures, Leslie Ventures and Anorak Ventures.
San Francisco–based Osso VR designed its surgical training technology to provide on-demand, educational experiences that are repeatable and measurable to help surgeons with surgical techniques and technologies.
Osso VR says it experienced rapid growth last year to meet the increased demand in virtual training driven by the COVID-19 pandemic. The company works with medtech giants including Johnson & Johnson, Stryker, and Smith+Nephew, expanding into additional specialties including orthopedics, endoscopy, interventional procedures and more. Its surgical training library has more than 120 modules in more than 10 specialties.
“Osso VR is positioned to transform how surgeons are trained on new devices and surgical procedures,” said Dr. Sunny Kumar, a partner at GSR Ventures. “The Osso platform’s level of immersion provides an experience that mirrors the operating room in a manner more efficient, more accessible, and more effective than any surgical training platform that’s come before.”
Osso VR’s platform has visual fidelity and is available in multiple languages, including English, Japanese, Spanish, German and French. According to the company, nearly 30,000 training sessions have been completed on the platform and have been proven to significantly impact surgical performance. It is used in more than 20 global hospital residency programs, including Brown University, Hospital for Special Surgery, Johns Hopkins University and Rush University.
“Osso VR has been on an incredible journey. We have built a once-in-a-lifetime team, bringing together experts from healthcare, technology, movies and gaming to pursue our mission: improve patient outcomes, accelerate the adoption of more effective surgical technologies and democratize access to education. After proving the clinical effectiveness of the platform and its unique ability to scale up to the millions of providers around the world, we are ready to accelerate,” Osso VR CEO and cofounder Dr. Justin Barad said in a news release. “With this latest round, we plan to exponentially expand our library and platform so that every patient in the world can have the peace of mind knowing they are getting access to the safest, highest-value procedures.”